The Global Financial Crisis (GFC) has revealed certain weaknesses in financial regulation, generating both commentary and policy responses.
Newman House
Friday, May 20th
Within elements of this commentary, over the counter (OTC) financial derivative nstruments, in particular, have been held up as a prime example of a market warranting substantially more direct public regulatory intervention, exemplified by recent regulatory proposals emanating from the United States and the European Union. This conference will map out both the historical and emerging nature and operation of both public and private regulation in the OTC derivatives markets. This offers participants a sense of where OTC derivatives regulation has been and where it is likely to go in the future, including its capacity to cope with challenges thrown up by the GFC. This will be coupled with an emphasis on OTC equity derivatives and the particular challenges they present to traditional corporate governance paradigms.
This includes discussion both of the potential benefits of OTC equity derivatives as well as their capacity to skew incentives in the market for corporate control and facilitate a sidestepping of public disclosure rules
To see the brochure click here .
To download the booking form click here .